General population hepatitis B virus immunization intervention scenarios for Ontario
| Scenario | Administration | Predicted immunization coverage | |||||
|---|---|---|---|---|---|---|---|
| 2021 | 2022–2023 | 2024–2050 | 2021 | 2022–2023 | 2024–2050 | ||
| Birth dose coverage, % | Three-dose coverage, % | ||||||
| 1. Base (current adolescent schedule) | Two pediatric HBV vaccine doses in grade 7 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2. Three individual doses (0, 1 and 6 mo) | Three pediatric HBV vaccine doses in the first year of life | 75 | 90 | 95 | 75 | 90 | 95 |
| 3. Two individual, 1 combined (0, 1 and 6 mo) | Two pediatric HBV vaccine doses, final dose hexavalent vaccine on the same schedule as current pentavalent vaccine | 75 | 90 | 95 | 75 | 90 | 95 |
| 4. One individual, 2 combined (0, 2 and 6 mo) | One dose of pediatric HBV vaccine, 2 doses of hexavalent vaccine on the same schedule as current pentavalent vaccine | 75 | 90 | 95 | 75 | 90 | 95 |
| 5. Three combined (2, 4 and 6 mo) | Three doses of hexavalent vaccine on the same schedule as current pentavalent vaccine | 0 | 0 | 0 | 75 | 90 | 95 |
Note: HBV = hepatitis B virus.